Not Every Patient With HCC is the Same: The Need for More Equitable Liver Cancer Screening

Not Every Patient With HCC is the Same: The Need for More Equitable Liver Cancer Screening

Andrea Branch, PhD, Professor of Medicine, Division of Liver Diseases, explains the global importance of hepatocellular carcinoma (HCC), the predominant histological type of liver cancer; describes liver cancer screening guidelines and demonstrates how they may disadvantage Black patients; and identifies barriers to optimal liver cancer screening that impacts all patients.

Referring a patient is easy. Just click the “Refer a Patient Online” button.


Published

July 20, 2021

Created by

Physician's Channel - Mount Sinai New York

Featured Faculty

Andrea Branch, PhD

Andrea Branch, PhD

Professor of Medicine, Division of Liver Diseases
Associate Professor of Surgery
Icahn School of Medicine at Mount Sinai

View full profile